Business ❯ Healthcare

Market Trends

Sales Growth Pharmaceutical Industry Weight Loss Drugs Consumer Access Growth Projections Biotech Industry COVID-19 Treatments Procedure Volumes Competitive Landscape Pharmaceutical Sales Investor Demand Outsourcing Patient Accessibility Drug Pricing Aging Population Product Demand Patient Volume COVID-19 Products Investor Expectations Revenue Growth Demand Analysis Competition Cancer Diagnostics Consumer Demand GLP-1 Medications Weight Loss Medications Global Expansion COVID-19 Impact Procedure Volume Growth Mergers and Acquisitions Consumer Wellness

Pfizer Tops Q4 Estimates but Posts Loss on $4.4 Billion Charge, Reaffirms 2026 Outlook

Management reiterates a flat 2026 outlook centered on cost cuts, obesity programs, pivotal trials.

Intuitive Surgical Tops Q4, Guides Slower 2026 Procedure Growth

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Eli Lilly Shifts to Access-First Strategy on GLP-1 Strength

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Medtronic Tops Q2 Estimates, Lifts Outlook on Cardiovascular and Diabetes Strength

Intuitive Surgical Rallies on Q3 Beat as Analysts Lift Targets, Cite Valuation Limits

Zimmer Biomet Cuts Organic Growth Outlook to 4% Upper Range as Shares Fall on Q3 Update

Intuitive Surgical’s Rally Spurs New Trefis Case for $699

Roche to Acquire 89bio in Deal Worth Up to $3.5 Billion

Biogen to Buy Alcyone for $85 Million, Gaining Rights to ThecaFlex DRx